ESC 365 - Effects of the chymase inhibitor fulacimstat on adverse cardiac remodelling after acute myocardial infarction - Results of the CHIARA MIA 2 trial

ESC Premium Access

Effects of the chymase inhibitor fulacimstat on adverse cardiac remodelling after acute myocardial infarction - Results of the CHIARA MIA 2 trial

Session: New strategies in acute coronary syndrome management

Topic: Left Ventricular Remodelling

Speaker: Professor H. Duengen (Berlin, DE)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Hans-Dirk Duengen

Scirent - Clinical Research and Science, Berlin (Germany)

1 presentation

0 follower

4 more presentations in this session

Unanswered questions in acute coronary syndromes: do we know enough in 2019?

Speaker: Professor K. Fox (Edinburgh, GB)

Coronary CT angiography as the first-line diagnostic strategy in patients with Non-ST-segment Elevation Acute Coronary Syndrome - The VERDICT trial

Speaker: Associate Professor K. Kofoed (Copenhagen, DK)

Oxygen therapy in myocardial infarction patients with or without diabetes mellitus - A predefined subgroup analysis from the DETO2X-AMI trial

Speaker: Doctor R. Hofmann (Stockholm, SE)

What do we do for patients not adressed in guidelines?

Speaker: Doctor R. Califf (Durham, US)

Access the full session

New strategies in acute coronary syndrome management

Speakers: Professor H. Duengen, Professor K. Fox, Associate Professor K. Kofoed, Doctor R. Hofmann, Doctor R. Califf

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources